SciRise Logo
    Insights

    Implications of AI for Academic Medicine

    December 16, 2025Michael J. Fern

    AI is often discussed as a set of discrete tools. That's the wrong mental model.

    AI is a general purpose technology, like electricity, computing, or the Internet. History is pretty consistent on what happens next:

    • Lots of new tools emerge
    • Most get bolted onto existing processes
    • Very few deliver measurable impact

    That pattern is already playing out with AI. Many deployments are add-ons to legacy workflows. Useful in spots, but rarely transformational.

    The Real Value Requires Redesign

    The real value of general purpose technologies shows up only when organizations redesign the "factory layout." In academic medicine, that means reorganizing work around AI with the right complements in place:

    • Data readiness — Clean, structured, accessible
    • System integration — EHR + research + finance + HR, not siloed pilots
    • Workflow instrumentation — So impact is measurable
    • Governance & risk — Privacy, compliance, safety, accountability
    • Training — Operational fluency, not just prompt tips

    Without these, AI becomes a hammer: powerful, but prone to shallow answers, brittle outputs, and trust-eroding failures (especially when the question is poorly scoped or the data is low quality).

    What This Means for Academic Medicine

    • AI will not deliver value if it is bolted on
    • The biggest gains require redesigning core infrastructure and workflows
    • Academic medicine is unusually exposed to "hammer and nail" risk because the work is especially complex, high-stakes, and compliance-constrained

    Where Early Impact Will Show Up

    Early measurable impact will likely show up in mission-critical (unglamorous) infrastructure where redesign has lagged:

    AreaPotential Impact
    Research administrationMore proposals managed per FTE; faster IRB and contracting cycles
    Administrative opsAbsorb growth with fewer net new hires; lower cost per transaction
    Clinical productivityIncreased clinician capacity via reduced documentation and inbox burden
    Clinical revenueLower revenue-cycle friction (fewer denials, faster prior auth)

    The Institutions That Win

    The institutions that win will focus on capacity creation, not just cost reduction.

    AI will not transform academic medicine by making people faster at legacy workflows. It will transform it by enabling entirely new ways of organizing work.

    AI deployment is a leadership imperative, where administrative leaders (e.g., Deans and Vice Deans, including operational Vice Deans and Chief Administrative Officers) can play a central role in workflow redesign, governance, and incentives.

    Questions?